EULAR 2025 highlights… EULAR 2025 Highlights – Rare and Autoinflammatory diseases 18 Jul 202518 Jul 2025 A WINDOW OF OPPORTUNITY IN STILL’S DISEASE: THE EARLY INTRODUCTION OF IL-1 INHIBITORS FOR ACHIEVING CLINICAL INACTIVE DISEASE Abstract format and assignment number: Poster 0377 Presenting author: S. Bindoli (Italy)…
ACR Highlights… ACR Convergence 2024 Highlights – Rare and Autoinflammatory diseases 19 Dec 202419 Dec 2024 Damage associated with disease-specific events and diagnostic or therapeutic procedures is highly prevalent in IgG4-related disease Abstract format and assignment number: Poster 0286 Presenting author: J. Stone (US) Date: Saturday,…
EULAR 2024 Highlights… EULAR 2024 Highlights – Rare and Autoinflammatory diseases 21 Jul 202421 Jul 2024 Author: Francesca Crisafulli Jachiet et al. (OP0231) evaluated retrospectively the efficacy and safety of azacitidine (AZA) treatment in 57 VEXAS patients, including 50 with myelodysplastic syndrome (MDS) and 7 without, from the French national…
ACR Highlights… ACR Convergence Highlights 2023 – Rare & Autoinflammatory diseases 9 Dec 20239 Dec 2023 Author: Dálifer Freites Núñez Brown et al. (0280) characterized the largest cohort of patients suffering from Susac Syndrome, a rare autoimmune condition causing microvascular occlusions in the brain, retina and inner ear leading to…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – Rare & Autoinflammatory Diseases 6 Nov 20238 Nov 2023 Gozde Kubra YardimciGozde completed her rheumatology fellowship at Hacettepe University Medical Faculty in Ankara, and has started her VCRC-Vasculitis Foundation Fellowship. She is currently working as a clinical & research fellow at…
Rare & Autoinflammatory diseases [EULAR HL 2023] Rare and autoinflammatory diseases 20 Jun 2023 M. Lanzillotta et al. (OP0251) characterized the epidemiology, clinical manifestations, and response to treatment of IgG4-RD patients in Europe. 1079 individuals with were screened but only 735 were diagnosed with IgG4-RD. 45% had multiorgan involvement.…